Ferring Pharmaceuticals Ltd is a global pharmaceutical company specializing in the research, development, manufacturing, and commercialization of innovative medicines. Established in 1975, the company operates as a limited company with a registered address at Drayton Hall, West Drayton, UB7 7PS, United Kingdom. Ferring focuses on providing specialized pharmaceutical products across a range of therapeutic areas, including cardiovascular, respiratory, and oncology. The company’s core business revolves around the development and marketing of prescription medicines, with a particular emphasis on complex formulations and specialized treatments. Ferring’s expertise lies in the discovery, development, and commercialization of novel therapies, leveraging its extensive research capabilities and robust manufacturing infrastructure. Ferring’s international presence is significant, with operations spanning across Europe, North America, and Asia. The company actively pursues strategic partnerships and collaborations to expand its market reach and product portfolio. Ferring is currently operating as a Skilled Worker, holding a Worker rating and actively seeking to recruit skilled personnel. The company’s key focus is on delivering high-quality medicines to patients worldwide. SIC Codes include: - 46460 (Wholesale of pharmaceutical goods) and potentially other relevant codes depending on specific business activities.

Ferring Pharmaceuticals Ltd is a global pharmaceutical company specializing in the research, development, manufacturing, and commercialization of innovative medicines. Established in 1975, the company operates as a limited company with a registered address at Drayton Hall, West Drayton, UB7 7PS, United Kingdom. Ferring focuses on providing specialized pharmaceutical products across a range of therapeutic areas, including cardiovascular, respiratory, and oncology. The company’s core business revolves around the development and marketing of prescription medicines, with a particular emphasis on complex formulations and specialized treatments. Ferring’s expertise lies in the discovery, development, and commercialization of novel therapies, leveraging its extensive research capabilities and robust manufacturing infrastructure. Ferring’s international presence is significant, with operations spanning across Europe, North America, and Asia. The company actively pursues strategic partnerships and collaborations to expand its market reach and product portfolio. Ferring is currently operating as a Skilled Worker, holding a Worker rating and actively seeking to recruit skilled personnel. The company’s key focus is on delivering high-quality medicines to patients worldwide. SIC Codes include: - 46460 (Wholesale of pharmaceutical goods) and potentially other relevant codes depending on specific business activities.